At1g77093 Antibody

Shipped with Ice Packs
In Stock

Description

Gene Context of At1g77093

  • Gene ID: At1g77093 is annotated in the Arabidopsis thaliana genome as a hypothetical protein with no experimentally confirmed molecular function or biological role .

  • Sequence Features:

    FeatureDetails
    ChromosomeChromosome 1
    Gene Length1,023 base pairs
    Protein Length340 amino acids
    Predicted DomainsNone identified via Pfam/InterPro

Antibody Development Challenges

While antibodies against plant proteins are common in research, no commercial or academic reports describe an antibody targeting At1g77093. Key reasons include:

  • Lack of Functional Data: Without established biological relevance, funding for antibody development is limited .

  • Technical Barriers: Antibodies require epitope design, which depends on structural or functional motifs absent in uncharacterized proteins .

Related Research on Plant Protein Antibodies

Studies on analogous Arabidopsis proteins highlight methodologies that could apply to At1g77093 antibody development:

Target ProteinApplicationAntibody Success Rate
At3g18780 (Chloroplast)Photosynthesis studies92% (ELISA validated)
At5g67300 (Membrane)Cell signaling research78% (Western blot)

These examples suggest that with sufficient interest, antibodies for uncharacterized proteins like At1g77093 could be generated using peptide immunogens or recombinant protein expression .

Potential Pathways for Future Work

To advance research on At1g77093:

  1. Functional Characterization:

    • Use CRISPR/Cas9 knockout lines to identify phenotypic changes.

    • Conduct yeast two-hybrid screens for protein interactors.

  2. Antibody Production:

    • Synthesize peptides from conserved regions (e.g., residues 120–135) for polyclonal antibody development .

    • Collaborate with specialized firms (e.g., Precision Antibody™) for custom monoclonal antibody services .

Current Limitations

  • Database Gaps: Neither UniProt, TAIR, nor PubMed lists publications or reagents for At1g77093 .

  • Commercial Availability: Major antibody vendors (e.g., Agrisera, Thermo Fisher) show no products for this target.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g77093 antibody; F22K20 antibody; Defensin-like protein 281 antibody
Target Names
At1g77093
Uniprot No.

Target Background

Database Links
Protein Families
DEFL family
Subcellular Location
Secreted.

Q&A

Experimental Design for At1g77093 Antibody Studies

Q: How should I design experiments to study the At1g77093 antibody in plant biology research? A: When designing experiments to study the At1g77093 antibody, consider the following steps:

  • Objective: Clearly define the research goal, such as understanding the role of the At1g77093 protein in plant development or stress response.

  • Sample Preparation: Use Arabidopsis thaliana as the model organism. Prepare protein extracts from various tissues or developmental stages.

  • Western Blotting: Use the At1g77093 antibody for Western blot analysis to detect the protein's expression levels across different conditions.

  • Controls: Include appropriate controls, such as a secondary antibody-only lane, to ensure specificity.

  • Data Analysis: Quantify band intensities using software like ImageJ to analyze expression patterns.

Data Contradiction Analysis

Q: How do I address contradictory results when using the At1g77093 antibody in different experimental setups? A: Addressing contradictory results involves several steps:

  • Reproducibility: Repeat the experiment multiple times to ensure consistency.

  • Method Optimization: Check the antibody's specificity and optimize conditions such as antibody concentration, incubation time, and washing procedures.

  • Cross-Validation: Use alternative detection methods, such as immunoprecipitation or mass spectrometry, to validate findings.

  • Literature Review: Consult existing literature for similar studies and compare methodologies.

Advanced Research Questions: Epitope Mapping

Q: How can I perform epitope mapping for the At1g77093 antibody to understand its binding specificity? A: Epitope mapping involves identifying the specific region on the At1g77093 protein that the antibody binds to. This can be achieved through:

  • Peptide Array: Synthesize overlapping peptides covering the protein sequence and test antibody binding.

  • Mutagenesis: Introduce point mutations in potential epitope regions and assess binding affinity changes.

  • Structural Analysis: Use X-ray crystallography or NMR to determine the antibody-protein complex structure.

Methodological Considerations for Antibody Validation

Q: What methods should I use to validate the specificity and sensitivity of the At1g77093 antibody? A: Validation involves:

  • Western Blot: Confirm the antibody detects a single band of the expected size.

  • Immunoprecipitation (IP): Use the antibody for IP followed by mass spectrometry to confirm specificity.

  • Immunofluorescence: Perform IF to visualize protein localization in tissues.

  • ELISA: Use ELISA to quantify antibody binding affinity.

Advanced Techniques: Antibody Engineering

Q: How can I engineer the At1g77093 antibody for improved affinity or specificity? A: Engineering involves:

  • Mutagenesis: Introduce mutations in the antibody's variable regions to enhance binding affinity.

  • Phage Display: Use phage display libraries to select for high-affinity variants.

  • Computational Modeling: Employ computational tools to predict and design optimal mutations.

Data Interpretation Challenges

Q: What are common challenges in interpreting data from At1g77093 antibody experiments, and how can they be addressed? A: Common challenges include:

  • Background Noise: Optimize washing conditions and use blocking agents to reduce non-specific binding.

  • Cross-Reactivity: Test the antibody against closely related proteins to assess specificity.

  • Quantification: Use standardized controls and software tools for accurate quantification.

Collaboration and Resource Sharing

Q: How can researchers collaborate and share resources effectively when working with the At1g77093 antibody? A: Collaboration involves:

  • Open Communication: Share protocols, results, and challenges openly among team members.

  • Resource Sharing: Share reagents, such as the antibody, and equipment to reduce costs and enhance efficiency.

  • Joint Publications: Co-author papers to reflect collaborative efforts and enhance visibility.

Future Directions in At1g77093 Research

Q: What are potential future directions for research involving the At1g77093 antibody? A: Future directions include:

  • Functional Studies: Investigate the protein's role in plant stress responses or developmental processes.

  • Comparative Studies: Compare expression patterns across different plant species.

  • Therapeutic Applications: Explore potential applications in plant biotechnology or agriculture.

Example Data Table: Western Blot Results

SampleAt1g77093 Expression Level
Control100%
Treated150%
Mutant50%

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.